Who invested in Prazer Therapeutics?
Prazer Therapeutics's investors include Smilegate Investment and Premier Partners.
Who invested in Prazer Therapeutics
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $20MApr 2025
- Investors
- 2
The rounds
- Apr 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Prazer Therapeutics
How much has Prazer Therapeutics raised?
Prazer Therapeutics has raised $20M across 1 round since 2025.
When did Prazer Therapeutics last raise?
Prazer Therapeutics's most recent round was a Series B of $20M in Apr 2025.
What was Prazer Therapeutics's biggest round?
Its most recent round, $20M in Apr 2025, is also its largest on record.
Who backed Prazer Therapeutics first?
Prazer Therapeutics's first round on record, in Apr 2025, was backed by Smilegate Investment and Premier Partners.
What stage is Prazer Therapeutics at?
Prazer Therapeutics's latest named round is a Series B, in Apr 2025.
Companies like Prazer Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.